Evidence map›Paper›PMID 24799327›Full record

ArticleHepatology (Baltimore, Md.)2015

Reply: To PMID 24677197.

Bryan C Fuchs, Yujin Hoshida, Kenneth K Tanabe

Abstract readLetterComment
In one paragraph

Article in Hepatology (Baltimore, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Bryan C FuchsDivision of Surgical Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA.
Yujin Hoshida
Kenneth K Tanabe

Funding

TARGETTING DIFFUSE LIVER METASTASES WITH HERPES VIRUSR01CA076183 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI TANABE, KENNETH K · 2000 to 2010
$3.0M
Molecular Prognostic Indicators in Liver Cirrhosis and CancerR01DK099558 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HOSHIDA, YUJIN · 2013 to 2016
$2.6M
The Role of EGF in Human Hepatocellular TransformationK01CA140861 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FUCHS, BRYAN CHRISTOPHER · 2009 to 2013
$710k
NCI NIH HHS K01 CA140861NCI NIH HHS R01 CA076183NIDDK NIH HHS R01 DK099558
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease ProgressionAnimalsCarcinoma, HepatocellularErbB ReceptorsHumansLiver CirrhosisLiver NeoplasmsMaleQuinazolinesErbB ReceptorsQuinazolines

Identifiers

PMID24799327
PMCPMC4221577

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.